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Abstract
Background—Triclosan is an antimicrobial chemical used in consumer products, and exposure 
is ubiquitous among pregnant women in the United States. Triclosan may reduce the levels of 
thyroid hormones that are important for fetal growth and development.
Objective—We investigated the relationship of prenatal triclosan exposure with birth 
anthropometry and gestational duration.
Methods—We used data from 377 mother-child pairs participating in the Health Outcomes and 
Measures of the Environment (HOME) Study, a prospective pregnancy and birth cohort from 
Cincinnati, OH. We measured triclosan concentrations in maternal urine samples collected at 16 
and 26 weeks of pregnancy. We abstracted information on neonatal anthropometry and gestational 
duration from medical records. We used multivariable linear regression to estimate the covariate-
adjusted association between the average of the two urinary triclosan concentrations and 
gestational age standardized weight z-score, length, head circumference, and gestational age at 
birth.
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Results—Median urinary triclosan concentrations were 16 ng/mL (range: <2.4 to 1,501 ng/mL). 
Each 10-fold increase in triclosan was associated with a predicted 0.15 standard deviation decrease 
(95% CI: −0.30, 0.00) in birth weight z-score, 0.4-cm decrease (95% CI: −0.8, 0.1) in birth length, 
0.3-cm decrease (95% CI: −0.5, 0.0) in head circumference, and 0.3-week decrease (95% CI: −0.6, 
−0.1) in gestational age. Child sex did not modify the associations between triclosan and birth 
outcomes.
Conclusions—In this cohort, maternal urinary triclosan concentrations during pregnancy were 
inversely associated with infants’ birth weight, length, head circumference, and gestational age.
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Introduction
Triclosan is an antimicrobial chemical that is widely used in some toothpastes, 
mouthwashes, soaps, cosmetics, lotions, textiles, toys, and kitchenware.1 Exposure is 
ubiquitous among pregnant women in the United States.2–4 The primary routes of exposure 
are oral and dermal, with the highest exposures hypothesized to be from dermally applied 
products.5 Oral care products, including some toothpastes, are another major source of 
exposure, particularly among children.5 The U.S. Food and Drug Administration banned 
over-the-counter consumer wash products that contain triclosan in September of 2016; 
however other potential sources of triclosan, such as some body lotions and toothpastes, 
remain in use.6
Triclosan may disrupt the actions within the hypothalamic-pituitary-thyroid axis7, and 
triclosan exposure reduces thyroxine concentrations in pregnant, fetal, and juvenile rats.8–10 
Of particular concern is the potential for triclosan to disrupt thyroid hormone homeostasis 
during fetal development because thyroid hormones play a critical role in fetal growth and 
neurodevelopment; reduced thyroxine levels during gestation can have negative impacts on 
the developing fetus.11–13
Triclosan has been associated with adverse birth outcomes in epidemiological studies. 
Maternal prenatal urinary triclosan concentrations have been inversely associated with 
newborn’s head circumference, but not with weight or length at birth.14,15 Another study 
found that prenatal urinary triclosan concentrations were inversely associated with birth 
weight and length among newborn boys, but not with head circumference.3 However, prior 
studies were limited by having only one measure of prenatal urinary triclosan during 
pregnancy and this may have resulted in exposure misclassification.
The objective of this study was to investigate the relationship of prenatal urinary triclosan 
concentrations at 16 and 26 weeks of pregnancy with birth weight, length, head 
circumference, and gestational duration in a prospective pregnancy and birth cohort. Based 
on previous animal and epidemiologic studies, we hypothesized that urinary triclosan 
concentrations would be inversely associated with neonatal anthropometry and gestational 
duration.
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We used data collected from women and children enrolled in The Health Outcomes and 
Measures of the Environment (HOME) Study, an ongoing prospective pregnancy and birth 
cohort in the greater Cincinnati, Ohio metropolitan area. The HOME Study was designed to 
investigate the impact of exposure to common environmental contaminants on child health 
and development. We previously described details of the study.16 Briefly, from March 2003 
to January 2006 we recruited women living in the greater Cincinnati, Ohio metropolitan area 
who were: 18 years or older and 16±3 weeks of gestation, spoke English, lived in a home 
built before 1978, and had no history of HIV infection or other medical conditions such as 
diabetes, bipolar disorder, schizophrenia or cancer that resulted in radiation treatment or 
chemotherapy. Of the 1,263 eligible women we approached, 468 (37%) agreed to participate 
in our study. Of these, 67 dropped out before delivery leaving 401 women who delivered 389 
singletons, 3 stillbirths, and 9 sets of twins.
The Cincinnati Children’s Hospital Medical Center (CCHMC) and participating delivery 
hospitals’ Institutional Review Boards (IRB) approved the HOME Study. After research 
assistants explained study protocols, all women provided written informed consent for 
themselves and their children. Brown University relinquished IRB authority to CCHMC 
through an Interagency Agreement. The Centers for Disease Control and Prevention (CDC) 
also relied on CCHMC IRB.
Urinary Triclosan Biomarkers
Women provided two urine samples at an average of 16.0 (range: 10.4–22.6) and 26.5 
(range: 19.1–34.6) weeks of gestation. We collected urine in polypropylene containers and 
stored them at −20°C until shipped to the CDC for analysis. We measured total (conjugated 
+ free) urinary triclosan concentrations using online solid phase extraction coupled with 
high performance liquid chromatography-isotope dilution tandem mass spectrometry as 
previously described.17 Concentrations below the limit of detection (LOD) of 2.3 ng/mL 
were given a value of LOD/√2 for the statistical analysis. Urinary triclosan concentrations 
were creatinine-standardized (μg/g creatinine) to control for individual variation in urine 
dilution. Because creatinine-standardized urinary triclosan concentrations were right 
skewed, we log10-transformed them to reduce the influence of extreme observations before 
taking the mean of the 16 and 26-week log10-transformed creatinine-standardized urinary 
triclosan concentrations. Ninety-four percent of women had triclosan measurements at 16 
and 26 weeks; for those who had only one measure, we used that in place of the mean.
Birth Outcomes
We extracted birth weight, length, and head circumference, gestational duration, and the 
method for determining gestational age (last menstrual period, n=368; antenatal ultrasound, 
n=6; or Ballard Maturational Assessment, n=3) from newborn medical charts. We calculated 
sex and gestational age standardized birth weight z-scores using United States Natality 
datasets.18
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We considered adjusting for potential confounders that might be associated with both 
gestational triclosan concentrations and fetal growth or gestational duration using a directed 
acyclic graph (DAG) (Supplemental Figure S1). We collected information about 
sociodemographic factors including maternal race and ethnicity, age, education, marital 
status, and household income using a computer-assisted questionnaire administered by 
trained research staff during the second trimester of pregnancy. Depressive symptoms were 
measured with the Beck Depression Inventory (BDI-II) at 20 weeks of pregnancy 19. We 
measured perinatal factors, including delivery method, parity, weight at 16 weeks gestation, 
and prenatal vitamin use using standardized interviews or medical chart reviews. We 
assessed tobacco smoke exposure using the average of serum cotinine concentrations taken 
at 16 and 26 weeks of pregnancy.20
Statistical Analysis
Of the 389 women in the HOME Study who gave birth to singletons, we excluded women 
who had offspring with congenital or chromosomal abnormalities (n=2), were missing the 
method used to determine gestational age (n=1), or were missing covariate data (n=8). This 
left 378 mother-neonate pairs for analysis of birth weight z-score and gestational age. Eight 
children were missing the head circumference measurements and 9 children were missing 
the birth length measurements, leaving 370 and 369 mother-neonate pairs for the analysis of 
head circumference and birth length, respectively.
We started our statistical analysis by calculating the geometric mean of the average prenatal 
triclosan concentrations and the mean birth weight z-score by covariates. Next, we 
calculated intraclass correlation coefficients (ICCs) between the 16 and 26 week log10-
transformed creatinine-standardized urinary triclosan concentrations to estimate the 
reproducibility of the repeated urinary triclosan concentrations.21
We then determined whether there were non-linear relationships between urinary triclosan 
concentrations and birth outcomes using restricted cubic splines.22 Because we observed a 
linear association (non-linearity p-values>0.3), we estimated the unadjusted and adjusted 
difference in birth weight z-score, gestational age, birth head circumference, and birth length 
associated with a 10-fold increase in gestational urinary triclosan concentration using 
multivariable linear regression. To enhance interpretability of the results, we also examined 
the adjusted mean value in birth outcomes across quartiles of prenatal urinary triclosan 
concentrations. We examined whether child sex modified the association between triclosan 
and birth outcomes in our multivariable model by including child sex and a product 
interaction term between triclosan concentrations and child sex. Finally, we used Poisson 
regression with robust standard errors to calculate the relative risk of low-birth weight 
(<2500 grams), preterm birth (<37 weeks gestation), and small for gestational age (SGA, 
<10th birth weight z-score percentile) for a 10-fold increase in prenatal triclosan 
concentrations. 23 We used SAS version 9.4 (SAS Institute, Inc. Cary, NC) and R version 3.2 
for statistical analysis.
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We conducted several sensitivity analyses to evaluate the robustness of our results: 1) We 
adjusted for a reduced set of covariates that were shown to be the most influential 
confounders; these covariates included maternal age, race, education, marital status, income, 
and cotinine concentrations; 2) Since gestational diabetes and hypertensive disorders during 
pregnancy can influence fetal growth (Supplemental Figure S2), we excluded women who 
had either (n=10 for gestational diabetes and n=30 for hypertension disorders);24 3) Due to 
differences in methods of measuring gestational age, we restricted our analysis to women 
who had gestational age measured by LMP (n=368); 4) Because exposure to other phenols 
may impact birth outcomes (Supplemental Figure S2)3,14, we adjusted for urinary 2,4-
dichlorophenol, 2,5-dichlorophenol, bisphenol A, benzophenone-3, methylparaben, 
propylparaben, and butylparaben concentrations. 5) We excluded women who were missing 
a urine sample at either 16 or 26 weeks to ensure that these women were not unduly 
influencing our results; 6) To identify potential periods of heightened vulnerability during 
gestation, we examined the difference in birth outcomes associated with a 10-fold increase 
in prenatal urinary triclosan concentration at 16 and 26 weeks separately; 7) To determine if 
our methods to adjust for urine dilution were sensitive to various assumptions, we conducted 
additional analyses employing six other urine dilution adjustment methods described by 
O’Brien et al. (2016). We also excluded women who had extreme creatinine values < 0.3 g/L 
or > 3.0 g/L (n=7).
Results
Mothers in the cohort were predominately white (62%), college-educated (56%), 
multiparous (55%), married (65%), and between the ages of 25 and 34 (60%) (Table 1).
Triclosan was detected in 91 and 83% of the 16 and 26 week urine samples, respectively 
(Supplemental Table S1). Median urinary triclosan concentrations were slightly higher at 16 
weeks (17 ng/mL, range: <LOD-1,985 ng/mL) than at 26 weeks (13 ng/mL, range: 
<LOD-1,657 ng/mL) (Supplemental Figure S3, Supplemental Table S1). The median of the 
average prenatal urinary triclosan concentration was 16 ng/mL (range: <LOD-1,501 ng/mL). 
Repeated unstandardized (ICC=0.42, 95% CI: 0.33, 0.50) and creatinine-standardized 
(ICC=0.53; 95% CI: 0.45, 0.60) urinary triclosan concentrations at 16 and 26 weeks had fair 
reproducibility. Geometric mean prenatal urinary triclosan concentrations were slightly 
higher among women who were >25 to 35 years of age, white, had a bachelor’s degree or 
higher, married, had a household income more than $40,000 a year, had minimal depressive 
symptoms, took prenatal vitamins weekly or daily, and were non-smokers, but not all 
differences were statistically significant (Table 1).
The mean (±standard deviation [SD]) birth weight, birth weight z-score, birth length, head 
circumference, and gestational duration were 3,378 grams (±618 grams), 0.06 standard 
deviation units (±1.0), 51 cm (±3.0), 34 cm (±1.8), and 39 weeks (±1.8 weeks), respectively. 
At delivery, 33 (8.7%) were low birth weight, 19 infants (5.0%) were preterm, and 31 infants 
(8.2%) were SGA. Average birth weight z-scores were significantly lower among women 
who were <25 years of age at delivery, non-Hispanic black, less educated, had a lower 
household income, unmarried, nulliparous, lower BMI, rarely or never took prenatal 
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vitamins, exposed to secondhand tobacco smoke or smokers, and not diagnosed with 
gestational diabetes (Table 1).
In unadjusted models, we observed weak inverse or null associations between prenatal 
urinary triclosan concentrations and all four outcomes (Table 2). After adjusting for 
covariates, prenatal urinary triclosan concentrations were inversely associated with the four 
birth outcomes, although some of the 95% CI’s included the null value (Table 2, 
Supplemental Figure S4). Each 10-fold increase in triclosan was associated with an 
estimated 0.15 standard deviation decrease (95% CI: −0.30, 0.00) in birth weight z-score, 
0.4-cm decrease (95% CI: −0.8, 0.1) in birth length, 0.3-cm decrease (95% CI: −0.5, 0.0) in 
head circumference, and 0.3-week decrease (95% CI: −0.6, −0.1) in gestational age. There 
was no evidence of effect modification by child sex; all sex x triclosan effect modification p-
values were >0.6 (Table 2).
We observed monotonic decreases in mean birth weight z-score across increasing prenatal 
urinary triclosan concentration quartiles, whereas mean birth length, head circumference, 
and gestational duration generally decreased across the first three quartiles and then slightly 
increased from the third to fourth quartiles (Figure 1, Supplemental Table S2). For example, 
neonates born to women in the 4th quartile of triclosan concentrations had 0.26 SD units 
lower birth weight z-score (95% CI: −0.55, −0.02) than neonates born to women in the 1st 
quartile. Neonates born to women in the 2nd, 3rd, and 4th quartile of triclosan concentrations 
had a gestational age that was 0.1 weeks (95% CI: −0.6, 0.4), 0.6 weeks (95% CI: −1.1, 0.1), 
and 0.5 weeks (95% CI: −1.0, 0.1) smaller, respectively, than neonates born to women in the 
1st quartile.
Higher prenatal urinary triclosan concentrations were associated with a slight and imprecise 
increase in risk for low birth weight, preterm birth, and SGA (Table 3). After adjusting for 
covariates, there was a 30–40% higher risk of low birth weight (RR=1.4, 95% CI: 0.8, 2.4), 
preterm birth (RR=1.4, 95% CI: 0.9, 2.3), or SGA (RR=1.3, 95% CI: 0.9, 2.1) for every 10-
fold increase in prenatal urinary triclosan concentrations.
Sensitivity Analyses
In trying to identify which individual covariates were responsible for the observed negative 
confounding, we found an inverse relation between prenatal urinary triclosan concentrations 
and birth outcomes when individually adjusting for maternal age, race, education, marital 
status, household income, and serum cotinine concentrations during pregnancy 
(Supplemental Figure S5); the results of models only adjusting for these covariates was not 
appreciably different than the model that included our full set of covariates (Supplemental 
Table S3). Adjusting for gestational duration attenuated the association of prenatal urinary 
triclosan concentrations with birth length and head circumference (Supplemental Table S3). 
Excluding women with gestational diabetes or hypertension disorders, restricting the 
analysis to women with only LMP gestational duration measurements, excluding women 
who only had one prenatal urine sample, and adjusting for other phenols did not appreciably 
change the association between prenatal urinary triclosan concentrations and birth outcomes 
(Supplemental Table S3).
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The associations between prenatal triclosan concentrations taken during the second and third 
trimester and birth outcomes were slightly attenuated and had greater precision than the 
association between average prenatal triclosan concentration and birth outcomes 
(Supplemental Table S4). For example, each 10-fold increase in 16 and 26-week triclosan 
concentrations was associated with a 0.12 (95% CI: −0.27, 0.03) and 0.12 (95% CI: −0.26, 
0.02) SD-unit decrease in birth weight z-score, respectively.
The associations between prenatal urinary triclosan concentrations and birth outcomes were 
similar when we used different methods to adjust for urine dilution or excluded women with 
extreme creatinine values (Supplemental Table S5).
Discussion
Among 378 mother-infant pairs in the HOME Study, we found that higher urinary triclosan 
concentrations measured during pregnancy were associated with modest reductions in birth 
weight, length, head circumference, and gestational duration. In addition, higher gestational 
urinary triclosan concentrations were associated with a modestly elevated risk of low birth 
weight, preterm birth, and SGA. We found an attenuation of birth length and head 
circumference estimates when adjusting for gestational duration. However, gestational age is 
a strong predictor of fetal growth and our gestational age-adjusted estimates would be 
attenuated because we were adjusting for a causal intermediate.
Some of our results are consistent with previous epidemiological studies observing inverse 
associations between prenatal urinary triclosan concentrations and birth outcomes.3,14,15 
Similar to Wolff et al. (2008), we found an inverse association between prenatal urinary 
triclosan concentrations and birth length and weight. However, Wolff et al. (2008) only 
found this association among boys. In contrast, Lassen et al. (2016) and Philippat et al. 
(2014) did not find any association between prenatal urinary triclosan concentrations and 
birth weight and length. Consistent with our findings, Philippat et al. (2014) and Lassen et 
al. (2016) observed an inverse association between prenatal triclosan concentrations and 
head circumference at birth, but this was not observed by Wolff et al. (2008). Wolff et al. 
(2008) did not observe an association between prenatal triclosan concentrations and 
gestational age; Lassen et al. (2016) and Philippat et al. (2014) did not examine gestational 
age as one of their outcomes.
Differences in the results of this and previous studies could be explained by the number and 
timing of urine sample collections. We had two measures of urinary triclosan concentrations 
during the 2nd and 3rd trimesters of pregnancy. In contrast, all three previous studies only 
had one measure taken during either the 2nd or 3rd trimester. Two measurements may 
enhance the accuracy of gestational triclosan exposure assessment. Others have concluded 
that a single measure of urinary triclosan concentrations could result in non-differential 
exposure misclassification and this could explain the lack of associations in some previous 
studies.25
It does not appear that discrepancies in study results are related to differences in the central 
tendency of triclosan concentrations. For instance, Lassen at al. (2016) observed an inverse 
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association between prenatal triclosan concentrations and birth weight, despite having the 
lowest median urinary triclosan concentrations (1.0 ng/mL) compared to the HOME Study 
(median=16 ng/mL) and Philippat et al. (2014) study (median=30 ng/mL). Inconsistencies 
could also be due to differences in the attributes of the study participant characteristics. For 
instance, Philippat et al. (2014) studied a cohort of women who had male infants.
Previous research suggests that prenatal triclosan exposure could affect several biological 
mechanisms involved in fetal growth. Triclosan may disrupt the homeostasis of thyroid 
hormones by reducing the availability of thyroxine through increased hepatic 
metabolism.7,8,26 Several studies have shown that triclosan exposure reduces thyroxine 
concentrations in pregnant and fetal rats.7,10,26,27 A decrease in thyroxine availability during 
pregnancy could be detrimental for the growth and development of the fetus since the fetal 
thyroid does not become functional until the 12th week of gestation, making the fetus 
exclusively dependent on maternal thyroxine during the first trimester.11 Because thyroid 
hormones play a critical role in brain development during fetal development, triclosan 
exposure may adversely affect brain development and growth.12,13,28
This study has some potential limitations that should be considered. First, triclosan exposure 
may be misclassified due to the moderate within-person variability of urinary triclosan 
concentrations. Triclosan has a half-life <24 hours 29 and exposures are likely be episodic in 
nature. Thus, accurate exposure assessment can be challenging. However, a strength of our 
study is that we had two triclosan measurements during the second and third trimesters of 
pregnancy and >94% of women had a measure in both trimesters. Assuming non-differential 
exposure misclassification of our urinary triclosan biomarker, it is likely that our reported 
results would be attenuated towards the null.30
Another limitation of the present study is that a majority of women had gestational age 
measured by LMP instead of an ultrasound, which is a more accurate method of pregnancy 
dating. However, previous research has shown that LMP reasonably approximates 
gestational age obtained from an ultrasound in the first trimester.31 Generalizability is a third 
potential limitation of this study because our cohort is predominantly white and college 
educated (Table 1). However, the average triclosan concentration is consistent with the 
nationally representative National Health and Nutrition Examination Survey (NHANES) 
triclosan concentrations (17 ng/mL) and we have no evidence to suggest that women in the 
HOME Study are more susceptible to the effects of triclosan.4,32 Fourth, different methods 
of adjusting for urine dilution could also result in exposure misclassification. Previous 
research based on simulations has shown that not adjusting for urine dilution introduces 
more bias compared to other statistical methods of urine dilution adjustment.33 However, we 
used several different methods to adjust for urine dilution and our results did not vary by the 
method of adjustment
Finally, while we adjusted for many potential confounders, there is the possibility of residual 
confounding from other factors associated with both triclosan exposure and fetal growth or 
gestational duration. We observed that the relationship between urinary triclosan 
concentrations and neonatal size or gestational duration was negatively confounded by 
sociodemographic factors.34 Women who were white, older, more educated, married, and 
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had a higher household income had higher urinary triclosan concentrations, and their infants 
had better birth outcomes compared to other women. This finding, in particular the 
association between household income and triclosan concentrations, is consistent with 
results from NHANES.32 Given the observed negative confounding by sociodemographic 
factors in these data, the presence of any residual negative confounding from other 
unmeasured sociodemographic factors suggests that the results presented here would be 
biased towards the null. However, there is still a possibility of positive confounding from 
factors that are associated with poor birth outcomes and higher triclosan exposure. It is also 
important to consider other chemical exposures correlated with triclosan and birth outcomes 
as potential confounders. Reassuringly, our results did not change when we adjusted for 
several other urinary phenol biomarkers.
In this cohort, maternal urinary triclosan concentrations during pregnancy were associated 
with a decrease in birth weight, length, head circumference, and gestational duration. These 
findings suggest that triclosan exposure during pregnancy may be associated with adverse 
birth outcomes. While we did not find evidence that the association between triclosan and 
birth outcomes depended on the timing of exposure in the latter-two thirds of pregnancy, 
future research could attempt to identify windows of heightened vulnerability to triclosan 
using repeated assessments of exposure and statistically appropriate methods.35 Finally, 
more research is needed to understand the relation between early life triclosan exposure and 
other infant and child health outcomes.
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• Triclosan exposure was associated with reduced birth weight.
• Triclosan exposure was also associated with a reduction in gestational age.
• These associations were not different in boys and girls.
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Adjusted mean birth weight z-score, birth length, head circumference, and gestational age by 
maternal urinary triclosan quartiles in the HOME Study (2003–2006). *Adjusted for 
maternal race, education, marital status, age at delivery, income, prenatal vitamin use, 
delivery method, BDI score, and maternal serum cotinine concentrations during pregnancy. 
Head circumference is also adjusted for delivery method. Mean birth outcomes are presented 
at the median triclosan concentration within each quartile.
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Table 1
Urinary triclosan concentrations during pregnancy and birth weight z-scores by covariates among women and 
their infants in the HOME study (2003–2006).
N (%) Triclosan Geometric Mean, ng/mL (GSD)a Mean Birth weight z-score (SD)
All Maternal Age (years) 378 19 (4.1) 0.06 (1.03)
 18–25 90 (24) 16 (3.6) −0.43 (0.86)
 >25–35 227 (60) 20 (4.4) 0.23 (0.98)
 >35 61 (16) 19 (3.5) 0.17 (1.22)
 p-value 0.17 <0.01
Maternal Race
 White 235 (62) 20 (4.3) 0.28 (1.05)
 Black 117 (31) 17 (3.8) −0.32 (0.89)
 Other 26 (7) 17 (3.9) −0.20 (0.87)
 p-value 0.57 <0.01
Maternal Education
 Bachelor’s/Grad/Prof 191 (51) 21 (4.4) 0.27 (1.06)
 Tech school/Some College 94 (25) 19 (4.2) −0.02 (0.93)
 High School 52 (14) 17 (3.6) −0.19 (1.08)
 <High School 41 (11) 14 (2.9) −0.42 (0.79)
 p-value 0.31 <0.01
Marital Status
 Married 245 (65) 21 (4.5) 0.25 (1.04)
 Not married (Living Alone) 55 (15) 16 (3.7) −0.21 (0.83)
 Not married (Living w/Someone) 78 (21) 15 (2.9) −0.34 (0.96)
 p-value 0.08 <0.01
Household Income
 >$80K 103 (27) 21 (3.9) 0.16 (0.97)
 $40–80K 128 (34) 22 (4.9) 0.37 (1.09)
 $20–40K 63 (17) 15 (3.9) −0.07 (1.00)
 <$20K 84 (22) 16 (3.1) −0.44 (0.80)
 p-value 0.17 <0.01
Parity
 Nulliparous 169 (45) 19 (4.2) −0.11 (1.04)
 1 to 2 117 (31) 18 (4.1) 0.19 (0.98)
 3+ 90 (24) 20 (3.9) 0.21 (1.04)
 p-value 0.94 0.01
Delivery Method
 Vaginal 269 (71) 18 (3.9) 0.00 (0.99)
 Cesarean 109 (29) 20 (4.4) 0.20 (1.12)
 p-value 0.62 0.09
Depressive Symptoms
 Minimal 294 (78) 20 (4.4) 0.10 (1.03)
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N (%) Triclosan Geometric Mean, ng/mL (GSD)a Mean Birth weight z-score (SD)
 Mild 53 (14) 15 (3.2) −0.09 (1.08)
 Moderate/Severe 31 (8) 17 (2.9) −0.04 (0.92)
 p-value 0.30 0.39
Maternal BMI* (kg/m2)
 <25 161 (43) 18 (3.9) −0.12 (0.98)
 25–30 124 (33) 21 (4.4) 0.14 (1.01)
 >30 93 (25) 17 (4.0) 0.27 (1.08)
 p-value 0.44 0.01
Prenatal Vitamin
 Rarely/Never 56 (15) 14 (3.3) −0.23 (0.91)
 Weekly/Daily 322 (85) 20 (4.2) 0.11 (1.04)
 p-value 0.09 0.02
Child Sex
 Female 204 (54) 18 (4.0) −0.02 (0.96)
 Male 174 (46) 20 (4.2) 0.15 (1.10)
 p-value 0.43 0.1
Tobacco Smoke Exposureb
 Unexposed 140 (37) 23 (4.5) 0.26 (1.08)
 Secondhand Smoke 197 (52) 17 (4.0) −0.03 (0.98)
 Active 41 (11) 15 (3.0) −0.17 (0.99)
 p-value 0.12 0.01
Gestational Diabetes
 Yes 10 (3) 15 (3.2) 0.79 (1.55)
 No 319 (97) 19 (4.2) 0.05 (1.03)
 p-value 0.62 0.03
Hypertension Disorders
 Yes 30 (8) 21 (5.3) −0.19 (1.06)
 No 346 (92) 19 (4.0) 0.08 (1.03)
 p-value 0.62 0.16
a
Triclosan concentrations are from the mean of the 16-week and 26-week urinary concentrations. These values are not adjusted for urine dilution.
b
Smoking status is based on prenatal serum cotinine concentrations; < 0.015ng/mL was classified as unexposed, 0.014 to ≤ 3.0 ng/mL was 
classified as secondhand smoke, and >3.0 ng/mL was considered active smoking exposure.
*
BMI: Body Mass Index
*
p-values reflect the difference in the urinary triclosan geometric mean among the different categories.
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Table 3
Unadjusted and adjusted relative risk for low birth weight, preterm birth, and SGA per 10-fold increase in 
prenatal urinary triclosan concentrations among women in the HOME study (2003–2006).
Outcome Number with outcome (%) Crude RR (95% CI) Adjusted RR (95% CI)1
Low birth weight (<2500 g) 33 (8.7) 1.1 (0.7, 1.9) 1.4 (0.8, 2.4)
Preterm Birth (<37 weeks) 19 (5.0) 1.2 (0.8, 1.9) 1.4 (0.9, 2.3)
SGA (<10th Percentile) 31 (8.2) 1.2 (0.8, 1.8) 1.3 (0.9, 2.1)
1
Adjusted for mother’s race, household income, age at delivery, education, marital status, BDI score, mother’s BMI, prenatal vitamin use, and 
maternal serum cotinine concentrations during pregnancy.
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